Abstract
Dr. Guido Zaman is Section Head Molecular in the Pharmacology Unit of N.V. Organon in Oss, the Netherlands. His section is responsible for assay development from cDNA to HTS, and in vitro biological testing from hit to clinical candidate. Guido completed his PhD in molecular biology on protein - RNA interaction at the University of Nijmegen in 1991, and studied multidrug resistance of human cancer cells at the Netherlands Cancer Institute in Amsterdam before joining Organon in 1996. In addition to serving as a guest editor of the mini-hot topic in this issue, Guido Zaman is a member of the Editorial Board of Assay & Drug Development Technologies.
Combinatorial Chemistry & High Throughput Screening
Title: Meet the Guest Editor
Volume: 8 Issue: 4
Author(s): Guido J.R. Zaman
Affiliation:
Abstract: Dr. Guido Zaman is Section Head Molecular in the Pharmacology Unit of N.V. Organon in Oss, the Netherlands. His section is responsible for assay development from cDNA to HTS, and in vitro biological testing from hit to clinical candidate. Guido completed his PhD in molecular biology on protein - RNA interaction at the University of Nijmegen in 1991, and studied multidrug resistance of human cancer cells at the Netherlands Cancer Institute in Amsterdam before joining Organon in 1996. In addition to serving as a guest editor of the mini-hot topic in this issue, Guido Zaman is a member of the Editorial Board of Assay & Drug Development Technologies.
Export Options
About this article
Cite this article as:
Zaman J.R. Guido, Meet the Guest Editor, Combinatorial Chemistry & High Throughput Screening 2005; 8 (4) . https://dx.doi.org/10.2174/1386207054020787
DOI https://dx.doi.org/10.2174/1386207054020787 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
What Makes Y Family Pols Potential Candidates for Molecular Targeted Therapies and Novel Biotechnological Applications
Current Molecular Medicine Secondary Metabolites from Cyanobacteria: Complex Structures and Powerful Bioactivities
Current Organic Chemistry New Agents – Manifold Consequences: The Management of Lung and Colorectal Cancer is Changing
Current Cancer Therapy Reviews Radiolabeled Nanoparticles for Cancer Diagnosis and Therapy
Anti-Cancer Agents in Medicinal Chemistry The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide
Current Cancer Drug Targets Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms
Anti-Cancer Agents in Medicinal Chemistry In vivo Cancer Imaging with Semiconductor Quantum Dots
Current Pharmaceutical Analysis Implication of Gastric Cancer Molecular Genetic Markers in Surgical Practice
Current Genomics Recent Advances in the Design and Synthesis of Prednisolone and Methylprednisolone Conjugates
Current Pharmaceutical Design Human Genetic Variation: A Foundation for Rational Diagnosis and Individualized Treatment of Lung Cancer
Current Pharmacogenomics and Personalized Medicine Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases
Recent Patents on Inflammation & Allergy Drug Discovery The Role of Protease-Activated Receptors for the Development of Myocarditis: Possible Therapeutic Implications
Current Pharmaceutical Design A Novel Finding: Macrophages Involved in Inflammation Participate in Acute Aortic Dissection Complicated with Acute Lung Injury
Current Molecular Medicine Stressed to Death: Targeting Endoplasmic Reticulum Stress Response Induced Apoptosis in Gliomas
Current Pharmaceutical Design Novel Synthesis, Reactions and anti-Cancer Activities of 4,4-Benzene-1,4- diylbis(6-phenyl-2-thioxo-1,2-dihydropyridine-3-carbonitrile)
Current Organic Chemistry Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review
Current Cancer Drug Targets Synthesis of Coumarin linked Naphthalimide Conjugates as Potential Anticancer and Antimicrobial Agents
Letters in Drug Design & Discovery Current Antioxidant Molecular Therapies for Oxidative Stress-Related Ailments
Current Gene Therapy Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?
Current Molecular Medicine Interaction Between Retinoids and Eicosanoids: Their Relevance to Cancer Chemoprevention
Current Nutrition & Food Science